Cumbre Pharmaceuticals Inc.
|
|
|
|
|
develop and commercialize a new antibiotic called CBR-2092- that it hoped would 'address the critical unmet needs in combating chronic and hard-to-treat bacterial infections especially those involving drug resistant strains' | |
Korean Distributor : ??? |
Products information :
|
|
|
|
|
|
|
|
|
|